metadata

library_name: setfit
tags:
  - setfit
  - sentence-transformers
  - text-classification
  - generated_from_setfit_trainer
datasets:
  - CabraVC/vector_dataset_stratified_ttv_split_2023-12-05_21-07
metrics:
  - accuracy
widget:
  - text: >-
      for the taliglucerase alfa NDA that set forth additional requirements for
      approval. Protalix will work with the FDA to determine next steps.


      In May 2010, the FDA issued a “complete response” letter requesting
      additional information in connection with our supplemental NDA seeking
      approval to use Sutent for the treatment of pancreatic neuroendocrine
      tumors. We have provided the requested information, including an analysis
      of independently reviewed scans, and are working with the FDA to pursue
      regulatory approval.


      In April 2010, we received a “complete response” letter from the FDA for
      the Genotropin Mark VII multidose disposable device submission. In August
      2010, we submitted our response to address the requests and
      recommendations included in the FDA letter.


      In June 2010, we received a “complete response” letter from the FDA for
      the Celebrex chronic pain supplemental NDA. We are working with the FDA to
      determine the next steps.


      In October 2009, we received a “complete response” letter from the FDA
      with respect to the supplemental NDA for Geodon for the treatment of acute
      bipolar mania in children and adolescents aged 10 to 17 years. In October
      2010, we submitted our response to address the issues raised in the FDA
      letter. In April 2010, we received a “warning letter” from the FDA with
      respect to the clinical trial in support of this supplemental NDA. We are
      working with the FDA to address the issues raised in the letter.


      Boehringer Ingelheim (BI), our alliance partner, holds the NDAs for
      Spiriva Handihaler and Spiriva Respimat. In September 2008, BI received a
      “complete response” letter from the FDA for the Spiriva Respimat
      submission. The FDA is seeking additional data, and we are coordinating
      with BI, which is working with the FDA to provide the additional
      information. A full response will be submitted to the FDA upon the
      completion of planned and ongoing studies.


      In September 2007, we received an “approvable” letter from the FDA for
      Zmax that set forth requirements to obtain approval for the pediatric
      acute otitis media (AOM) indication based on pharmacokinetic data. A
      supplemental filing for pediatric AOM and sinusitis remains under review.


      Two “approvable” letters were received by Wyeth in April and December 2007
      from the FDA for Viviant (bazedoxifene), for the prevention of
      post-menopausal osteoporosis, that set forth the additional requirements
      for approval. In May 2008, Wyeth received an “approvable” letter from the
      FDA for the treatment of post-menopausal osteoporosis. The FDA is seeking
      additional data, and we have been systematically working through these
      requirements and seeking to address the FDA’s concerns. In February 2008,
      the FDA advised Wyeth that it expects to convene an advisory committee to
      review the pending NDAs for both the treatment and prevention indications
      after we submit our response to the “approvable” letters. In April 2009,
      Wyeth received approval in the EU for CONBRIZA (the EU trade name for
      Viviant) for the treatment of post-menopausal osteoporosis in women at
      increased risk of fracture. Viviant was also approved in Japan in July
      2010 for the treatment of post-menopausal osteoporosis.


      In July 2007,
  - text: "year 2005, offset by a $663 million decline in Upgrade Advantage earned revenue. \n\nInformation Worker operating income increased in fiscal year 2006 primarily due to the revenue growth, partially offset by a $283 million or 15% increase in sales and marketing expenses related to supporting field sales efforts and a $71 million or 10% increase in research and development expenses. Headcount-related costs increased 14% during fiscal year 2006 reflecting both an 18% increase in headcount related to supporting field sales efforts and research and development investments in future products and an increase in salaries and benefits for existing headcount, partially offset by a decrease in stock-based compensation expense. Information Worker operating income growth for fiscal year 2005 was primarily due to the revenue growth and a $304 million decrease in stock-based compensation expense. Operating expenses were also impacted by a reduction in marketing campaign costs from the previous period associated with the launch of Office 2003. This decline was offset by an increase in headcount-related costs as a result of an increase in headcount and an increase in salaries and benefits for existing headcount. \n\n\_\n\nMicrosoft Business Solutions \n\n\_\n\nMicrosoft Business Solutions provides business management software solutions targeted to businesses of varying sizes. The main products consist of enterprise resource planning (“ERP”) solutions, customer relationship management (“CRM”) software, retail solutions, Microsoft Partner Program (“MSPP”), and related services. Microsoft Business Solutions also includes the Small\n\n\n\n\n\n\_\n\n\_\n\n\_\n\nand Mid-market Solutions and Partners (“SMS&P”), which focuses on sales to customers and partners in the small and mid-market customer segments. Revenue is derived from software and services sales, with software sales representing a significant amount of total revenue. Software revenues include both new software licenses and enhancement plans, which provide customers with future software upgrades over the period of the plan. Our solutions are delivered through a worldwide network of channel partners that provide services and local support. \n\nMicrosoft Business Solutions revenue increased in fiscal year 2006 driven by new users for Microsoft CRM and existing Dynamics ERP customers purchasing functionality and user licenses. The increase in Microsoft Business Solutions revenue in fiscal year 2005 was mainly due to 10% revenue growth in software partially offset by 25% decline in services revenue. The software revenue increase was driven by 9% growth in license revenue and 16% growth in enhancement revenue and was attributed to growth in ERP and CRM solutions and an increase in MSPP subscriptions. \n\nMicrosoft Business Solutions operating income increased in fiscal year 2006 reflecting the increase in revenue accompanied by a $56 million decrease in sales and marketing expense as a result of decreased net SMS&P spending.\_Headcount-related costs increased 3% reflecting both a 10% increase in headcount and an increase in salaries and benefits for existing headcount, partially offset by a decrease in stock-based compensation expense."
  - text: "2004\n\n\n\nManagement's Discussion and Analysis of Financial Condition and Results of Operations\n\nThis section and other parts of this Form\_10-K contain forward-looking statements that involve risks and uncertainties. Forward-looking statements can also be identified by words such as \"anticipates,\" \"expects,\" \"believes,\" \"plans,\" \"predicts,\" and similar terms. Forward-looking statements are not guarantees of future performance and the Company's actual results may differ significantly from the results discussed in the forward-looking statements. Factors that might cause such differences include, but are not limited to, those discussed in the subsection entitled \"Factors That May Affect Future Results and Financial Condition\" below. The following discussion should be read in conjunction with the consolidated financial statements and notes thereto included in Item 8 of this Form\_10-K. All information presented herein is based on the Company's fiscal calendar. The Company assumes no obligation to revise or update any forward-looking statements for any reason, except as required by law.\n\nExecutive Overview\n\nApple designs, manufactures and markets personal computers and related software, services, peripherals and networking solutions. The Company also designs, develops and markets a line of portable digital music players along with related accessories and services including the online distribution of third-party music and audio books. The Company's products and services include the Macintosh line of desktop and notebook computers, the iPod digital music player, the Xserve server and Xserve RAID storage products, a portfolio of consumer and professional software applications, the Mac\_OS\_X operating system, the online iTunes Music Store, a portfolio of peripherals that support and enhance the Macintosh and iPod product lines, and a variety of other service and support offerings. The Company sells its products worldwide through its online stores, its own retail stores, its direct sales force, and third-party wholesalers, resellers and value added resellers. In addition, the Company sells a variety of third-party Macintosh compatible products, including computer printers and printing supplies, storage devices, computer memory, digital video and still cameras, personal digital assistants, and various other computing products and supplies through its online and retail stores. The Company sells to education, consumer, creative professional, business and government customers. A further description of the Company's products may be found in Part\_I, Item\_1 of this document under the heading \"Business.\"\n\nThe Company's business strategy leverages its unique ability, through the design and development of its own operating system, hardware and many software applications and technologies, to bring to its customers around the world compelling new products and solutions with superior ease-of-use, seamless integration and innovative industrial design.\n\nThe Company participates in several highly competitive markets, including personal computers with its Macintosh line of computers, consumer electronics with its iPod line of digital music players and distribution of"
  - text: >-
      we have access to significant distribution networks in rural and suburban
      areas in Brazil and the opportunity to register and commercialize Teuto’s
      products in various markets outside Brazil. For additional information,
      see also Notes to Consolidated Financial Statements—Note 2D. Acquisitions,
      Divestitures, Collaborative Arrangements and Equity-Method Investments:
      Equity-Method Investments.


      • On October 6, 2010, we completed our acquisition of FoldRx
      Pharmaceuticals, Inc. (FoldRx), a privately held drug discovery and
      clinical development company. FoldRx’s lead product candidate, Vyndaqel
      (tafamidis meglumine), was approved in the EU in November 2011 and our new
      drug application was accepted for review in the U.S. in February 2012.
      This product is a first-in-class oral therapy for the treatment of
      transthyretin familial amyloid polyneuropathy (TTR-FAP), a progressively
      fatal genetic neurodegenerative disease, for which liver transplant is the
      only treatment option currently available. Our acquisition of FoldRx has
      increased our presence in the growing rare medical disease market, which
      complements our Specialty Care unit. For additional information regarding
      Vyndaqel (tafamidis meglumine), see the “Product
      Developments—Biopharmaceutical” section of this Financial Review. The
      total consideration for the acquisition was approximately $400 million.
      For additional information about the acquisition, see Notes to
      Consolidated Financial Statements—Note 2A. Acquisitions, Divestitures,
      Collaborative Arrangements and Equity-Method Investments: Acquisitions.


      Our Financial Guidance for 2013


      We forecast 2013 revenues of $56.2 billion to $58.2 billion, Reported
      diluted earnings per common share (EPS) of $1.50 to $1.65 and Adjusted
      diluted EPS of $2.20 to $2.30. The exchange rates assumed in connection
      with the 2013 financial guidance are as of mid-January 2013. For an
      understanding of Adjusted income and Adjusted diluted EPS (both non-GAAP
      financial measures), see the “Adjusted Income” section of this Financial
      Review.


      The 2013 financial guidance reflects the benefit of a full-year
      contribution from Zoetis. We plan to update this guidance in April 2013 to
      reflect the impact of the recent initial public offering (IPO) of an
      approximate 19.8% ownership interest in Zoetis. For additional information
      on the IPO, see Notes to Consolidated Financial Statements—Note 19A.
      Subsequent Events: Zoetis Debt Offering and Initial Public Offering.


      The following table provides a reconciliation of 2013 Adjusted income and
      Adjusted diluted EPS guidance to 2013 Reported net income attributable to
      Pfizer Inc. and Reported diluted EPS attributable to Pfizer Inc. common
      shareholders guidance:


      Our 2013 financial guidance is subject to a number of factors and
      uncertainties—as described in the “Forward-Looking Information and Factors
      That May Affect Future Results”, “Our Operating Environment” and “Our
      Strategy” sections of this Financial Review and in Part I, Item 1A, “Risk
      Factors”, of our 2012 Annual Report on Form 10-K.


      SIGNIFICANT ACCOUNTING POLICIES AND APPLICATION OF CRITICAL ACCOUNTING
      ESTIMATES


      For a description of our significant accounting policies, see Notes to
  - text: >-
      as a component of Other (income) expense, net; and 


      a $ 56 million decrease in foreign exchange losses related to the
      difference between actual foreign currency exchange rates and standard
      foreign currency exchange rates assigned to the NIKE Brand geographic
      operating segments and Converse, net of hedge gains; these losses are
      reported as a component of consolidated gross margin. 


      Foreign Currency Exposures and Hedging Practices 


      Overview 


      As a global company with significant operations outside the United States,
      in the normal course of business we are exposed to risk arising from
      changes in currency exchange rates. Our primary foreign currency exposures
      arise from the recording of transactions denominated in non-functional
      currencies and the translation of foreign currency denominated results of
      operations, financial position and cash flows into U.S. Dollars. 


      Our foreign exchange risk management program is intended to lessen both
      the positive and negative effects of currency fluctuations on our
      consolidated results of operations, financial position and cash flows. We
      manage global foreign exchange risk centrally on a portfolio basis to
      address those risks that are material to NIKE, Inc. We manage these
      exposures by taking advantage of natural offsets and currency correlations
      that exist within the portfolio and, where practical and material, by
      hedging a portion of the remaining exposures using derivative instruments
      such as forward contracts and options. As described below, the
      implementation of the NIKE Trading Company (“NTC”) and our foreign
      currency adjustment program enhanced our ability to manage our foreign
      exchange risk by increasing the natural offsets and currency correlation
      benefits that exist within our portfolio of foreign exchange exposures.
      Our hedging policy is designed to partially or entirely offset the impact
      of exchange rate changes on the underlying net exposures being hedged.
      Where exposures are hedged, our program has the effect of delaying the
      impact of exchange rate movements on our Consolidated Financial
      Statements; the length of the delay is dependent upon hedge horizons. We
      do not hold or issue derivative instruments for trading or speculative
      purposes. 


      Transactional Exposures 


      We conduct business in various currencies and have transactions which
      subject us to foreign currency risk. Our most significant transactional
      foreign currency exposures are: 


      • Product Costs — NIKE’s product costs are exposed to fluctuations in
      foreign currencies in the following ways: 


      Product purchases denominated in currencies other than the functional
      currency of the transacting entity: 


      Certain NIKE entities, including those supporting our North America,
      Greater China, Japan and European geographies, purchase product from the
      NTC, a wholly-owned sourcing hub that buys NIKE branded products from
      third-party factories, predominantly in U.S. Dollars. The NTC, whose
      functional currency is the U.S. Dollar, then sells the products to NIKE
      entities in their respective functional currencies. When the NTC sells to
      a NIKE entity with a different functional currency, the result is a
      foreign currency exposure for the NTC. 


      Other
pipeline_tag: text-classification
inference: true
model-index:
  - name: SetFit
    results:
      - task:
          type: text-classification
          name: Text Classification
        dataset:
          name: CabraVC/vector_dataset_stratified_ttv_split_2023-12-05_21-07
          type: CabraVC/vector_dataset_stratified_ttv_split_2023-12-05_21-07
          split: test
        metrics:
          - type: accuracy
            value: 0.625
            name: Accuracy

SetFit

This is a SetFit model trained on the CabraVC/vector_dataset_stratified_ttv_split_2023-12-05_21-07 dataset that can be used for Text Classification. A MLP instance is used for classification.

The model has been trained using an efficient few-shot learning technique that involves:

Fine-tuning a Sentence Transformer with contrastive learning.
Training a classification head with features from the fine-tuned Sentence Transformer.

Model Details

Model Description

Model Type: SetFit
Classification head: a MLP instance
Maximum Sequence Length: 512 tokens
Number of Classes: 3 classes
Training Dataset: CabraVC/vector_dataset_stratified_ttv_split_2023-12-05_21-07

Model Sources

Repository: SetFit on GitHub
Paper: Efficient Few-Shot Learning Without Prompts
Blogpost: SetFit: Efficient Few-Shot Learning Without Prompts

Model Labels

Label	Examples
BUY	'mix, the mix of sales by us and by other sellers, our continuing focus on in-stock inventory availability, our investment in new geographies and product lines, and the extent to which we choose to utilize outsource fulfillment providers. Accounts payable days were 62, 57, and 53 for 2008, 2007 and 2006. We expect some variability in accounts payable days over time since they are affected by several factors, including the mix of product sales, the mix of sales by other sellers, the mix of suppliers, seasonality, and changes in payment terms over time, including the effect of balancing pricing and timing of payment terms with suppliers. \n\nWe expect spending in technology and content will increase over time as we add computer scientists, software engineers, and employees involved in category expansion, editorial content, buying, merchandising selection, and systems support. We seek to efficiently invest in several areas of technology and content, including seller platforms, web services, digital initiatives, and expansion of new and existing product categories, as well as in technology infrastructure to enhance the customer experience, improve our process efficiencies and support our infrastructure web services. We believe that advances in technology, specifically the speed and reduced cost of processing power, the improved consumer experience of the Internet outside of the workplace through lower-cost broadband service to the home, and the advances of wireless connectivity, will continue to improve the consumer experience on the Internet and increase its ubiquity in people’s lives. We are investing in Amazon Web Services, which provides technology services that give developers access to technology infrastructure that they can use to enable virtually any type of business. A continuing challenge will be to continue to build and deploy innovative and efficient software that will best take advantage of continued advances in technology. \n\nOur financial reporting currency is the U.S. Dollar and changes in exchange rates significantly affect our reported results and consolidated trends. For example, if the U.S. Dollar weakens year-over-year relative to currencies in our international locations, our consolidated net sales, gross profit, and operating expenses will be higher than if currencies had remained constant. Likewise, if the U.S. Dollar strengthens year-over-year relative to currencies in our international locations, our consolidated net sales, gross profit, and operating expenses will be lower than if currencies had remained constant. We believe that our increasing diversification beyond the U.S. economy through our growing international businesses benefits our shareholders over the long term. We also believe it is important to evaluate our operating results and growth rates before and after the effect of currency changes. \n\nIn addition, the remeasurement of our 6.875% PEACS and intercompany balances can result in significant gains and charges associated with the effect of movements in currency exchange rates. Currency volatilities may continue, which may significantly impact (either positively or negatively) our reported results and' 'equal to the entire difference between the debt instruments’ amortized cost basis and its fair value. For available-for-sale debt instruments that are considered other-than-temporarily impaired due to the existence of a credit loss, if we do not intend to sell and it is more likely than not that we will not be required to sell the instrument before recovery of its remaining amortized cost basis (amortized cost basis less any current-period credit loss), we separate the amount of the impairment into the amount that is credit related and the amount due to all other factors. The credit loss component is recognized in earnings.\n\n\n\nWe performed an impairment review of our investment portfolio as of January 25, 2015. We concluded that our investments were appropriately valued and that no other than temporary impairment charges were necessary on our portfolio of available-for-sale investments as of January 25, 2015.\n\n\n\nStock-based Compensation\n\n\n\nOur stock-based compensation expense is associated with stock options, restricted stock units, or RSUs, performance stock units, or PSUs, and our employee stock purchase plan, or ESPP.\n\n\n\nDuring fiscal year 2015, we shifted away from granting stock options and toward granting RSUs and PSUs to reflect changing market trends for equity incentives at our peer companies. The number of PSUs that will ultimately vest is contingent on the Company’s level of achievement compared with the corporate financial performance target established by our Compensation Committee in the beginning of each fiscal year. The number of shares of our stock to be received at vesting ranges from 0% to 200% of the target amount.\n\n\n\nWe use the closing trading price of our common stock on the date of grant, minus a dividend yield discount, as the fair value of awards of RSUs and PSUs. The compensation expense for RSUs is recognized using a straight-line attribution method over the requisite employee service period, while compensation expense for PSUs is recognized using an accelerated amortization model. We estimate the fair value of shares to be issued under our ESPP using the Black-Scholes model at the commencement of an offering period in March and September of each year. Stock-based compensation for our ESPP is expensed using an accelerated amortization model.\n\n\n\nOur RSU and PSU awards are not eligible for cash dividends prior to vesting; therefore, the fair value of RSUs and PSUs is discounted by the dividend yield. Additionally, we estimate forfeitures annually based on historical experience and revise the estimates of forfeiture in subsequent periods if actual forfeitures differ from those estimates. If factors change, the compensation expense that we record under these accounting standards may differ significantly from what we have recorded in the current period.\n\n\n\nLitigation, Investigation and Settlement Costs\n\n\n\nFrom time to time, we are involved in legal actions and/or investigations by regulatory bodies. We are aggressively defending our current litigation matters. However, there are many uncertainties associated with any litigation or investigations, and we cannot be certain that these actions or other third-party claims' 'local, and foreign tax authorities. Management believes that adequate provision has been made for any adjustments that may result from tax examinations. However, the outcome of tax audits cannot be predicted with certainty. If any issues addressed in the Company’s tax audits are resolved in a manner not consistent with management’s expectations, the Company could be required to adjust its provision for income taxes in the period such resolution occurs. \n\nAs of September 25, 2010, the Company had $51 billion in cash, cash equivalents and marketable securities, an increase of $17 billion from September 26, 2009. The principal component of this net increase was the cash generated by operating activities of $18.6 billion, which was partially offset by payments for acquisition of property, plant and equipment of $2 billion and payments made in connection with business acquisitions, net of cash acquired, of $638 million. \n\nThe Company’s marketable securities investment portfolio is invested primarily in highly rated securities, generally with a minimum rating of single-A or equivalent. As of September 25, 2010 and September 26, 2009, $30.8 billion and $17.4 billion, respectively, of the Company’s cash, cash equivalents and marketable securities were held by foreign subsidiaries and are generally based in U.S. dollar-denominated holdings. The Company believes its existing balances of cash, cash equivalents and marketable securities will be sufficient to satisfy its working capital needs, capital asset purchases, outstanding commitments and other liquidity requirements associated with its existing operations over the next 12 months. \n\nCapital Assets \n\nThe Company’s capital expenditures were $2.6 billion during 2010, consisting of approximately $404 million for retail store facilities and $2.2 billion for other capital expenditures, including product tooling and manufacturing process equipment and corporate facilities and infrastructure. The Company’s actual cash payments for capital expenditures during 2010 were $2 billion. \n\nThe Company anticipates utilizing approximately $4.0 billion for capital expenditures during 2011, including approximately $600 million for retail store facilities and approximately $3.4 billion for product tooling and manufacturing process equipment, and corporate facilities and infrastructure, including information systems hardware, software and enhancements. \n\nHistorically the Company has opened between 25 and 50 new retail stores per year. During 2011, the Company expects to open 40 to 50 new stores, over half of which are expected to be located outside of the U.S. \n\nOff-Balance Sheet Arrangements and Contractual Obligations \n\nThe Company has not entered into any transactions with unconsolidated entities whereby the Company has financial guarantees, subordinated retained interests, derivative instruments, or other contingent arrangements that expose the Company to material continuing risks, contingent liabilities, or any other obligation under a variable interest in an unconsolidated entity that provides financing, liquidity, market risk, or credit risk support to the Company. \n\nAs of September 25, 2010, the Company had'
SELL	'estimates and changes to these estimates will cause the fair values of our stock awards and related stock-based compensation expense that we record to vary.\n\nWe record deferred tax assets for stock-based compensation awards that result in deductions on our income tax returns, based on the amount of stock-based compensation recognized and the fair values attributable to the vested portion of stock awards assumed in connection with a business combination, at the statutory tax rate in the jurisdiction in which we will receive a tax deduction. Because the deferred tax assets we record are based upon the stock-based compensation expenses in a particular jurisdiction, the aforementioned inputs that affect the fair values of our stock awards may also indirectly affect our income tax expense. In addition, differences between the deferred tax assets recognized for financial reporting purposes and the actual tax deduction reported on our income tax returns are recorded in additional paid-in capital. If the tax deduction is less than the deferred tax asset, the calculated shortfall reduces our pool of excess tax benefits. If the pool of excess tax benefits is reduced to zero, then subsequent shortfalls would increase our income tax expense.\n\nTo the extent we change the terms of our employee stock-based compensation programs, experience market volatility in the pricing of our common stock that increases the implied volatility calculation of publicly traded options in our stock, refine different assumptions in future periods such as forfeiture rates that differ from our current estimates, or assume stock awards from acquired companies that are different in nature than our stock award arrangements, among other potential impacts, the stock-based compensation expense that we record in future periods and the tax benefits that we realize may differ significantly from what we have recorded in previous reporting periods.\n\nResults of Operations\n\nImpact of Acquisitions\n\nThe comparability of our operating results in fiscal 2014 compared to fiscal 2013 is impacted by our acquisitions, primarily our acquisitions of Responsys in the third quarter of fiscal 2014, Tekelec in the first quarter of fiscal 2014 and Acme Packet in the fourth quarter of fiscal 2013.\n\nThe comparability of our operating results in fiscal 2013 compared to fiscal 2012 is impacted by our acquisitions, primarily our acquisitions of Acme Packet in the fourth quarter of fiscal 2013, Taleo Corporation (Taleo) in the fourth quarter of fiscal 2012 and RightNow Technologies, Inc. (RightNow) during the third quarter of fiscal 2012.\n\nIn our discussion of changes in our results of operations from fiscal 2014 compared to fiscal 2013 and fiscal 2013 compared to fiscal 2012, we may qualitatively disclose the impacts of our acquired products (for the one year period subsequent to the acquisition date) to the growth in our new software licenses revenues, cloud SaaS and PaaS revenues, software license updates and product support revenues, hardware systems products revenues and hardware systems support revenues where such qualitative discussions would be meaningful for an understanding of the factors that' 'the share repurchase program for 2015.\n\nResults of Operations\n\nThe following section presents the results of operations and variances on an after-tax basis for the company’s business segments – Upstream and Downstream – as well as for “All Other.” Earnings are also presented for the U.S. and international geographic areas of the Upstream and Downstream business segments. Refer to Note 12, beginning on page FS-37, for a discussion of the company’s “reportable segments.” This section should also be read in conjunction with the discussion in “Business Environment and Outlook” on pages FS-2 through FS-5.\n\nU.S. upstream earnings of $3.3 billion in 2014 decreased $717 million from 2013, primarily due to lower crude oil prices of $950 million. Higher depreciation expenses of $440 million and higher operating expenses of $210 million also contributed to the decline. Partially offsetting the decrease were higher gains on asset sales of $700 million in the current period compared with $60 million in 2013, higher natural gas realizations of $150 million and higher crude oil production of $100 million.\n\nU.S. upstream earnings of $4.0 billion in 2013 decreased $1.3 billion from 2012, primarily due to higher operating, depreciation and exploration expenses of $420 million, $350 million, and $190 million, respectively, and lower crude oil production of $170 million. Higher natural gas realizations of approximately $200 million were mostly offset by lower crude oil realizations of $170 million.\n\nThe company’s average realization for U.S. crude oil and natural gas liquids in 2014 was $84.13 per barrel, compared with $93.46 in 2013 and $95.21 in 2012. The average natural gas realization was $3.90 per thousand cubic feet in 2014, compared with $3.37 and $2.64 in 2013 and 2012, respectively.\n\nNet oil-equivalent production in 2014 averaged 664,000 barrels per day, up 1 percent from both 2013 and 2012. Between 2014 and 2013, production increases in the Permian Basin in Texas and New Mexico and the Marcellus Shale in western Pennsylvania were partially offset by normal field declines. Between 2013 and 2012, new production in the Marcellus Shale in western Pennsylvania and the Delaware Basin in New Mexico, along with the absence of weather-related downtime in the Gulf of Mexico, was largely offset by normal field declines.\n\nThe net liquids component of oil-equivalent production for 2014 averaged 456,000 barrels per day, up 2 percent from 2013 and largely unchanged from 2012. Net natural gas production averaged about 1.3 billion cubic feet per day in 2014, largely unchanged from 2013 and up 4 percent from 2012. Refer to the “Selected Operating Data” table on page FS-11 for a three-year comparative of production volumes in the United States.\n\nInternational Upstream\n\nInternational upstream earnings were $13.6 billion in 2014 compared with $16.8 billion in 2013. The decrease between periods was primarily due to lower crude oil prices and sales volumes of $2.0 billion and $400 million, respectively. Also contributing to the decrease were higher depreciation expenses of $1.0 billion, mainly related to impairments and other asset writeoffs, and higher operating and tax' 'hypothetical royalties generated from using our tradename) or (4)\xa0projected discounted future cash flows. We recognize an impairment charge if the asset’s carrying value exceeds its estimated fair value.\n\n\xa0\xa0\xa0\xa0\xa0Changes in assumptions or circumstances could result in an additional impairment in the period in which the change occurs and in future years. Factors which could cause impairment include, but are not limited to, (1)\xa0negative trends in our market capitalization, (2)\xa0volatile fuel prices, (3)\xa0declining passenger mile yields, (4)\xa0lower passenger demand as a result of the weakened U.S. and global economy, (5)\xa0interruption to our operations due to an employee strike, terrorist attack, or other reasons, (6)\xa0changes to the regulatory environment and (7)\xa0consolidation of competitors in the industry.\n\n\xa0\xa0\xa0\xa0\xa0 Long-Lived Assets . Our flight equipment and other long-lived assets have a recorded value of $20.4\xa0billion on our Consolidated Balance Sheet at December\xa031, 2009. This value is based on various factors, including the assets’ estimated useful lives and their estimated salvage values. We record impairment losses on long-lived assets used in operations when events and circumstances indicate the assets may be impaired and the estimated future cash flows generated by those assets are less than their carrying amounts. If we decide to permanently remove flight equipment or other long-lived assets from operations, we will evaluate those assets for impairment. For long-lived assets held for sale, we record impairment losses when the carrying amount is greater than the fair value less the cost to sell. We discontinue depreciation of long-lived assets when these assets are classified as held for sale.\n\n\xa0\xa0\xa0\xa0\xa0To determine impairments for aircraft used in operations, we group assets at the fleet-type level (the lowest level for which there are identifiable cash flows) and then estimate future cash flows based on projections of capacity, passenger mile yield, fuel costs, labor costs and other relevant factors. If impairment occurs, the impairment loss recognized is the amount by which the aircraft’s carrying amount exceeds its estimated fair value. We estimate aircraft fair values using published sources, appraisals and bids received from third parties, as available. For additional information about our accounting policy for the impairment of long-lived assets, see Note 1 of the Notes to the Consolidated Financial Statements. \n\n\n\n\xa0\xa0\xa0\xa0\xa0 Income Tax Valuation Allowance and Contingencies . We periodically assess whether it is more likely than not that we will generate sufficient taxable income to realize our deferred income tax assets, and we establish valuation allowances if recovery is deemed not likely. In making this determination, we consider all available positive and negative evidence and make certain assumptions. We consider, among other things, our deferred tax liabilities, the overall business environment, our historical earnings and losses, our industry’s historically cyclical periods of earnings and losses and potential, current and future tax planning strategies. We cannot presently determine when we will be able to generate sufficient taxable'
HOLD	'both historical and projected future operating results, the reversal of existing taxable temporary differences, taxable income in prior carryback years (if permitted) and the availability of tax planning strategies. A valuation allowance is required to be established unless management determines that it is more likely than not that the Company will ultimately realize the tax benefit associated with a deferred tax asset. \n\nAdditionally, undistributed earnings of a subsidiary are accounted for as a temporary difference, except that deferred tax liabilities are not recorded for undistributed earnings of a foreign subsidiary that are deemed to be indefinitely reinvested in the foreign jurisdiction. The Company has formulated a specific plan for reinvestment of undistributed earnings of its foreign subsidiaries which demonstrates that such earnings will be indefinitely reinvested in the applicable tax jurisdictions. Should we change our plans, we would be required to record a significant amount of deferred tax liabilities. \n\nThe Company's effective tax rate is expected to be approximately 23.0 percent to 24.0 percent in 2009. This estimated tax rate does not reflect the impact of any unusual or special items that may affect our tax rate in 2009. \n\nContingencies \n\nOur Company is subject to various claims and contingencies, mostly related to legal proceedings and tax matters (both income taxes and indirect taxes). Due to their nature, such legal proceedings and tax matters involve inherent uncertainties including, but not limited to, court rulings, negotiations between affected parties and governmental actions. Management assesses the probability of loss for such contingencies and accrues a liability and/or discloses the relevant circumstances, as appropriate. Management believes that any liability to the Company that may arise as a result of currently pending legal proceedings, tax matters or other contingencies will not have a material adverse effect on the financial condition of the Company taken as a whole. Refer to Note 13 of Notes to Consolidated Financial Statements. \n\nRecent Accounting Standards and Pronouncements \n\nRefer to Note 1 of Notes to Consolidated Financial Statements for a discussion of recent accounting standards and pronouncements. \n\nOperations Review \n\nWe manufacture, distribute and market nonalcoholic beverage concentrates and syrups. We also manufacture, distribute and market finished beverages. Our organizational structure as of December 31, 2008, consisted of the following operating segments, the first six of which are sometimes referred to as "operating groups" or "groups": Eurasia and Africa; Europe; Latin America; North America; Pacific; Bottling Investments; and Corporate. We revised previously reported group information to conform to our operating structure in effect as of December 31, 2008. For further information regarding our operating segments, including a discussion of changes made to our operating segments effective July 1, 2008, refer to Note 21 of Notes to Consolidated Financial Statements. \n\nBeverage Volume \n\nWe measure our sales volume in two ways: (1) unit cases of finished products and (2) concentrate' "the last month of each quarter, we may not be able to reduce our inventory purchase commitments in a timely manner in response to customer cancellations or deferrals.\n\n\n\nCharges to cost of sales for inventory provisions totaled $50.1 million, $89.9 million and $53.0 million, unfavorably impacting our gross margin by 1.2%, 2.1% and 1.3%, in fiscal years 2014, 2013 and 2012, respectively. Sales of inventory that was previously written-off or written-down totaled $43.4 million, $53.7 million and $71.1 million, favorably impacting our gross margin by 1.1%, 1.3% and 1.8% in fiscal years 2014, 2013 and 2012, respectively. As a result, the overall net effect on our gross margin from charges to cost of sales for inventory provisions and sales of items previously written-off or written-down was a 0.1% unfavorable impact in fiscal year 2014, a 0.8% unfavorable impact in fiscal year 2013 and a 0.5% favorable impact in fiscal year 2012.\n\nDuring fiscal years 2014, 2013 and 2012, the charges we took to cost of sales for inventory provisions were primarily related to the write-off of excess quantities of certain older generations of GPU and Tegra Processor products whose inventory levels were higher than our updated forecasts of future demand for those products. As a fabless semiconductor company, we must make commitments to purchase inventory based on forecasts of future customer demand. In doing so, we must account for our third-party manufacturers' lead times and constraints. We also adjust to other market factors, such as product offerings and pricing actions by our competitors, new product transitions, and macroeconomic conditions - all of which may impact demand for our products.\n\n\n\nPlease refer to the Gross Profit and Gross Margin discussion below in this Management's Discussion and Analysis for further discussion.\n\n\n\nWarranty Liabilities\n\n\n\nCost of revenue includes the estimated cost of product warranties that are calculated at the point of revenue recognition. Under limited circumstances, we may offer an extended limited warranty to customers for certain products. Our products are complex and may contain defects or experience failures due to any number of issues in design, fabrication, packaging, materials and/or use within a system. If any of our products or technologies contains a defect, compatibility issue or other error, we may have to invest additional research and development efforts to find and correct the issue. In addition, an error or defect in new products or releases or related software drivers after commencement of commercial shipments could result in failure to achieve market acceptance or loss of design wins. Also, we may be required to reimburse customers, including our customers’ costs to repair or replace products in the field.\n\n \n\nIncome Taxes\n\nWe recognize federal, state and foreign current tax liabilities or assets based on our estimate of taxes payable or refundable in the current fiscal year by tax jurisdiction. We recognize federal, state and foreign deferred tax assets or liabilities, as appropriate, for our estimate of future tax effects attributable to temporary differences and carryforwards; and we record a" 'the euro. The Europe segment represented approximately 23% and 26% of the Company’s total net sales for 2012 and 2011, respectively. \n\nNet sales in the Europe segment increased $9.1 billion or 49% during 2011 compared to 2010. The increase in net sales during 2011 was attributable primarily to the continued year-over-year increase in iPhone sales from carrier expansion and strong demand for iPhone 4, and increased sales of iPad and Mac, partially offset by a decrease in iPod sales. The Europe segment represented 26% and 29% of the Company’s total net sales for 2011 and 2010, respectively. \n\nJapan \n\nNet sales in the Japan segment increased $5.1 billion or 94% during 2012 compared to 2011. The growth in net sales during 2012 was primarily driven by increased demand for iPhone following the launches of iPhone 4S and iPhone 5, expanded distribution with a new iPhone carrier, strong demand for the new iPad and iPad 2, higher sales from the iTunes Store, and strength in the Japanese Yen relative to the U.S. dollar. The Japan segment represented approximately 7% and 5% of the Company’s total net sales for 2012 and 2011, respectively. \n\nNet sales in the Japan segment increased $1.5 billion or 37% during 2011 compared to 2010. The key contributors to Japan’s net sales growth were increased iPhone sales, strong sales of iPad, increased sales of Mac, and strength in the Japanese Yen relative to the U.S. dollar. The Japan segment represented 5% and 6% of the Company’s total net sales for 2011 and 2010, respectively. \n\nAsia-Pacific \n\nNet sales in the Asia-Pacific segment increased $10.7 billion or 47% during 2012 compared to 2011. The growth in net sales during 2012 was mainly due to increased demand for iPhone from the launch of iPhone 4S, strong demand for the new iPad and iPad 2, and higher Mac sales. Growth in the Asia Pacific segment was affected by the timing of iPhone and iPad product launches. iPhone 5 was launched in a limited number of countries in the Asia Pacific segment during the fourth quarter of 2012 and was not launched in China during 2012, and the new iPad that was introduced by the Company in March 2012 was not launched in China until the fourth quarter of 2012. The Asia-Pacific segment represented approximately 21% of the Company’s total net sales in both 2012 and 2011. \n\nNet sales in the Asia Pacific segment increased $14.3 billion or 174% during 2011 compared to 2010. The Company experienced particularly strong year-over-year net sales growth in its Asia Pacific segment during 2011, especially in Greater China, which includes Hong Kong and Taiwan. Korea and Australia also experienced strong year-over-year revenue growth. Higher net sales in the Asia Pacific segment were due mainly to the increase in iPhone sales primarily attributable to the strong demand for iPhone 4 and carrier expansion, strong sales of iPad, and increased Mac sales. The Asia Pacific segment represented 21% and 13% of the Company’s total net sales in 2011 and 2010, respectively. \n\nRetail \n\nNet sales in the Retail segment increased $4.7 billion or 33% during 2012 compared to 2011. The growth in net sales during 2012 was driven primarily by increased demand for'

Evaluation

Metrics

Label	Accuracy
all	0.625

Uses

Direct Use for Inference

First install the SetFit library:

pip install setfit

Then you can load this model and run inference.

from setfit import SetFitModel

# Download from the 🤗 Hub
model = SetFitModel.from_pretrained("setfit_model_id")
# Run inference
preds = model("year 2005, offset by a $663 million decline in Upgrade Advantage earned revenue. 

Information Worker operating income increased in fiscal year 2006 primarily due to the revenue growth, partially offset by a $283 million or 15% increase in sales and marketing expenses related to supporting field sales efforts and a $71 million or 10% increase in research and development expenses. Headcount-related costs increased 14% during fiscal year 2006 reflecting both an 18% increase in headcount related to supporting field sales efforts and research and development investments in future products and an increase in salaries and benefits for existing headcount, partially offset by a decrease in stock-based compensation expense. Information Worker operating income growth for fiscal year 2005 was primarily due to the revenue growth and a $304 million decrease in stock-based compensation expense. Operating expenses were also impacted by a reduction in marketing campaign costs from the previous period associated with the launch of Office 2003. This decline was offset by an increase in headcount-related costs as a result of an increase in headcount and an increase in salaries and benefits for existing headcount. 

 

Microsoft Business Solutions 

 

Microsoft Business Solutions provides business management software solutions targeted to businesses of varying sizes. The main products consist of enterprise resource planning (“ERP”) solutions, customer relationship management (“CRM”) software, retail solutions, Microsoft Partner Program (“MSPP”), and related services. Microsoft Business Solutions also includes the Small





 

 

 

and Mid-market Solutions and Partners (“SMS&P”), which focuses on sales to customers and partners in the small and mid-market customer segments. Revenue is derived from software and services sales, with software sales representing a significant amount of total revenue. Software revenues include both new software licenses and enhancement plans, which provide customers with future software upgrades over the period of the plan. Our solutions are delivered through a worldwide network of channel partners that provide services and local support. 

Microsoft Business Solutions revenue increased in fiscal year 2006 driven by new users for Microsoft CRM and existing Dynamics ERP customers purchasing functionality and user licenses. The increase in Microsoft Business Solutions revenue in fiscal year 2005 was mainly due to 10% revenue growth in software partially offset by 25% decline in services revenue. The software revenue increase was driven by 9% growth in license revenue and 16% growth in enhancement revenue and was attributed to growth in ERP and CRM solutions and an increase in MSPP subscriptions. 

Microsoft Business Solutions operating income increased in fiscal year 2006 reflecting the increase in revenue accompanied by a $56 million decrease in sales and marketing expense as a result of decreased net SMS&P spending. Headcount-related costs increased 3% reflecting both a 10% increase in headcount and an increase in salaries and benefits for existing headcount, partially offset by a decrease in stock-based compensation expense.")

Training Details

Training Set Metrics

Training set	Min	Median	Max
Word count	431	479.2917	532

Label	Training Sample Count
BUY	3
HOLD	6
SELL	15

Training Hyperparameters

batch_size: (6, 8)
num_epochs: (0, 32)
max_steps: -1
sampling_strategy: oversampling
body_learning_rate: (0.0, 0.0)
head_learning_rate: 0.0002
loss: CosineSimilarityLoss
distance_metric: cosine_distance
margin: 0.25
end_to_end: False
use_amp: False
warmup_proportion: 0.1
l2_weight: 0.08
max_length: 512
seed: 1003200212
eval_max_steps: -1
load_best_model_at_end: False

Framework Versions

Python: 3.11.6
SetFit: 1.0.1
Sentence Transformers: 2.2.2
Transformers: 4.35.2
PyTorch: 2.1.1
Datasets: 2.15.0
Tokenizers: 0.15.0

Citation

BibTeX

@article{https://doi.org/10.48550/arxiv.2209.11055,
    doi = {10.48550/ARXIV.2209.11055},
    url = {https://arxiv.org/abs/2209.11055},
    author = {Tunstall, Lewis and Reimers, Nils and Jo, Unso Eun Seo and Bates, Luke and Korat, Daniel and Wasserblat, Moshe and Pereg, Oren},
    keywords = {Computation and Language (cs.CL), FOS: Computer and information sciences, FOS: Computer and information sciences},
    title = {Efficient Few-Shot Learning Without Prompts},
    publisher = {arXiv},
    year = {2022},
    copyright = {Creative Commons Attribution 4.0 International}
}